메뉴 건너뛰기




Volumn 25, Issue 3, 2012, Pages 215-220

Neuromyelitis optica: Not a multiple sclerosis variant

Author keywords

Multiple sclerosis; Neuromyelitis optica; Neuropathology; Pathogenesis; Treatment

Indexed keywords

AQUAPORIN 4; ARBIDOL; AZATHIOPRINE; BERBAMINE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPROTEIN; MYCOPHENOLIC ACID; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA;

EID: 84860779782     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283533a3f     Document Type: Review
Times cited : (23)

References (53)
  • 1
    • 0000155864 scopus 로고
    • Myé lite subaiguë compliquée de né vrite optique
    • Devic E. Myé lite subaiguë compliquée de né vrite optique. Bull Med (Paris) 1894; 8:1033-1034.
    • (1894) Bull Med (Paris) , vol.8 , pp. 1033-1034
    • Devic, E.1
  • 3
    • 10344250945 scopus 로고    scopus 로고
    • A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
    • Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364:2106-2112.
    • (2004) Lancet , vol.364 , pp. 2106-2112
    • Lennon, V.A.1    Wingerchuk, D.M.2    Kryzer, T.J.3
  • 4
    • 23944444890 scopus 로고    scopus 로고
    • IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
    • Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202:473-477.
    • (2005) J Exp Med , vol.202 , pp. 473-477
    • Lennon, V.A.1    Kryzer, T.J.2    Pittock, S.J.3
  • 5
    • 33745839327 scopus 로고    scopus 로고
    • Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression
    • Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63:964-968.
    • (2006) Arch Neurol , vol.63 , pp. 964-968
    • Pittock, S.J.1    Weinshenker, B.G.2    Lucchinetti, C.F.3
  • 6
    • 77957572192 scopus 로고    scopus 로고
    • Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity
    • Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010; 16:1229-1236.
    • (2010) Mult Scler , vol.16 , pp. 1229-1236
    • Kim, W.1    Park, M.S.2    Lee, S.H.3
  • 7
    • 33745334334 scopus 로고    scopus 로고
    • Revised diagnostic criteria for neuromyelitis optica
    • Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66:1485-1489.
    • (2006) Neurology , vol.66 , pp. 1485-1489
    • Wingerchuk, D.M.1    Lennon, V.A.2    Pittock, S.J.3
  • 8
    • 77957601341 scopus 로고    scopus 로고
    • Neuromyelitis optica: A demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes
    • Parratt JD, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler 2010; 16:1156-1172.
    • (2010) Mult Scler , vol.16 , pp. 1156-1172
    • Parratt, J.D.1    Prineas, J.W.2
  • 9
    • 0036310181 scopus 로고    scopus 로고
    • A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
    • Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125:1450-1461.
    • (2002) Brain , vol.125 , pp. 1450-1461
    • Lucchinetti, C.F.1    Mandler, R.N.2    McGavern, D.3
  • 10
    • 60849102769 scopus 로고    scopus 로고
    • Immunoglobulins and complement in postmortem multiple sclerosis tissue
    • Barnett MH, Parratt JD, Cho ES, Prineas JW. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol 2009; 65:32-46.
    • (2009) Ann Neurol , vol.65 , pp. 32-46
    • Barnett, M.H.1    Parratt, J.D.2    Cho, E.S.3    Prineas, J.W.4
  • 11
    • 34249711828 scopus 로고    scopus 로고
    • Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis
    • Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
    • (2007) Brain , vol.130 , pp. 1224-1234
    • Misu, T.1    Fujihara, K.2    Kakita, A.3
  • 12
    • 34249650146 scopus 로고    scopus 로고
    • Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
    • Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130:1194-1205.
    • (2007) Brain , vol.130 , pp. 1194-1205
    • Roemer, S.F.1    Parisi, J.E.2    Lennon, V.A.3
  • 13
    • 69549127956 scopus 로고    scopus 로고
    • Intractable hiccup caused by medulla oblongata lesions: A study of an autopsy patient with possible neuromyelitis optica
    • Kobayashi Z, Tsuchiya K, Uchihara T, et al. Intractable hiccup caused by medulla oblongata lesions: a study of an autopsy patient with possible neuromyelitis optica. J Neurol Sci 2009; 285:241-245.
    • (2009) J Neurol Sci , vol.285 , pp. 241-245
    • Kobayashi, Z.1    Tsuchiya, K.2    Uchihara, T.3
  • 14
    • 84855959569 scopus 로고    scopus 로고
    • Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
    • Barnett MH, Prineas JW, Buckland ME, et al. Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler 2012; 18:108-112.
    • (2012) Mult Scler , vol.18 , pp. 108-112
    • Barnett, M.H.1    Prineas, J.W.2    Buckland, M.E.3
  • 15
    • 77954982900 scopus 로고    scopus 로고
    • Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study
    • Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010; 75:208-216.
    • (2010) Neurology , vol.75 , pp. 208-216
    • Takano, R.1    Misu, T.2    Takahashi, T.3
  • 16
    • 78349297966 scopus 로고    scopus 로고
    • Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
    • Lee DH, Metz I, Berthele A, et al. Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology. Neuropathol Appl Neurobiol 2010; 36:685-687.
    • (2010) Neuropathol Appl Neurobiol , vol.36 , pp. 685-687
    • Lee, D.H.1    Metz, I.2    Berthele, A.3
  • 17
    • 62349119109 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
    • Magana SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 72:712-717.
    • (2009) Neurology , vol.72 , pp. 712-717
    • Magana, S.M.1    Matiello, M.2    Pittock, S.J.3
  • 18
    • 84856369996 scopus 로고    scopus 로고
    • Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
    • Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 2012; 109:1245-1250.
    • (2012) Proc Natl Acad Sci USA , vol.109 , pp. 1245-1250
    • Hinson, S.R.1    Romero, M.F.2    Popescu, B.F.3
  • 19
    • 0345659199 scopus 로고    scopus 로고
    • Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms
    • Furman CS, Gorelick-Feldman DA, Davidson KG, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci USA 2003; 100:13609-13614.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 13609-13614
    • Furman, C.S.1    Gorelick-Feldman, D.A.2    Davidson, K.G.3
  • 20
    • 79953225158 scopus 로고    scopus 로고
    • Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding
    • Pisani F, Mastrototaro M, Rossi A, et al. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem 2011; 286:9216-9224.
    • (2011) J Biol Chem , vol.286 , pp. 9216-9224
    • Pisani, F.1    Mastrototaro, M.2    Rossi, A.3
  • 21
    • 79955541724 scopus 로고    scopus 로고
    • Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4M1/M23 isoforms and orthogonal arrays
    • Crane JM, Lam C, Rossi A, et al. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011; 286:16516-16524.
    • (2011) J Biol Chem , vol.286 , pp. 16516-16524
    • Crane, J.M.1    Lam, C.2    Rossi, A.3
  • 22
    • 84455169951 scopus 로고    scopus 로고
    • Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica
    • Ratelade J, Bennett JL, Verkman AS. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem 2011; 286:45156-45164.
    • (2011) J Biol Chem , vol.286 , pp. 45156-45164
    • Ratelade, J.1    Bennett, J.L.2    Verkman, A.S.3
  • 23
    • 58149171974 scopus 로고    scopus 로고
    • Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
    • Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008; 205:2473-2481.
    • (2008) J Exp Med , vol.205 , pp. 2473-2481
    • Hinson, S.R.1    Roemer, S.F.2    Lucchinetti, C.F.3
  • 24
    • 77956383249 scopus 로고    scopus 로고
    • Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
    • Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010; 133:2578-2591.
    • (2010) Brain , vol.133 , pp. 2578-2591
    • Marignier, R.1    Nicolle, A.2    Watrin, C.3
  • 25
    • 72949114659 scopus 로고    scopus 로고
    • Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
    • Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66:630-643.
    • (2009) Ann Neurol , vol.66 , pp. 630-643
    • Bradl, M.1    Misu, T.2    Takahashi, T.3
  • 26
    • 77249090731 scopus 로고    scopus 로고
    • Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
    • Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010; 133:349-361.
    • (2010) Brain , vol.133 , pp. 349-361
    • Saadoun, S.1    Waters, P.2    Bell, B.A.3
  • 27
    • 0033966090 scopus 로고    scopus 로고
    • Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
    • Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6:159-163.
    • (2000) Nat Med , vol.6 , pp. 159-163
    • Manley, G.T.1    Fujimura, M.2    Ma, T.3
  • 28
    • 84355166544 scopus 로고    scopus 로고
    • Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
    • Zhang H, Bennett JL, Verkman AS. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 2011; 70:943-954.
    • (2011) Ann Neurol , vol.70 , pp. 943-954
    • Zhang, H.1    Bennett, J.L.2    Verkman, A.S.3
  • 29
    • 79958765901 scopus 로고    scopus 로고
    • Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
    • Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 2011; 306:82-90.
    • (2011) J Neurol Sci , vol.306 , pp. 82-90
    • Jarius, S.1    Paul, F.2    Franciotta, D.3
  • 30
    • 72949093353 scopus 로고    scopus 로고
    • Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica
    • Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66:617-629.
    • (2009) Ann Neurol , vol.66 , pp. 617-629
    • Bennett, J.L.1    Lam, C.2    Kalluri, S.R.3
  • 31
    • 80053457747 scopus 로고    scopus 로고
    • Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years
    • Kim SH, Kim W, Li XF, et al. Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 2011; 68:1412-1420.
    • (2011) Arch Neurol , vol.68 , pp. 1412-1420
    • Kim, S.H.1    Kim, W.2    Li, X.F.3
  • 32
    • 79952762854 scopus 로고    scopus 로고
    • Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
    • Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 2011; 108:3701-3706.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 3701-3706
    • Chihara, N.1    Aranami, T.2    Sato, W.3
  • 33
    • 71849113120 scopus 로고    scopus 로고
    • Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
    • Uzawa A, Mori M, Ito M, et al. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol 2009; 256:2082-2084.
    • (2009) J Neurol , vol.256 , pp. 2082-2084
    • Uzawa, A.1    Mori, M.2    Ito, M.3
  • 34
    • 26444619864 scopus 로고    scopus 로고
    • IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis
    • Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005; 115:2731-2741.
    • (2005) J Clin Invest , vol.115 , pp. 2731-2741
    • Kaplin, A.I.1    Deshpande, D.M.2    Scott, E.3
  • 35
    • 0031920882 scopus 로고    scopus 로고
    • IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
    • Okuda Y, Sakoda S, Bernard CC, et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol 1998; 10:703-708.
    • (1998) Int Immunol , vol.10 , pp. 703-708
    • Okuda, Y.1    Sakoda, S.2    Bernard, C.C.3
  • 36
    • 62349105479 scopus 로고    scopus 로고
    • Distribution of the AQP4 water channel in normal human tissues: Protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles
    • Mobasheri A, Marples D, Young IS, et al. Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles. Channels (Austin) 2007; 1:29-38.
    • (2007) Channels (Austin) , vol.1 , pp. 29-38
    • Mobasheri, A.1    Marples, D.2    Young, I.S.3
  • 37
    • 68149148572 scopus 로고    scopus 로고
    • Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis
    • Quintana A, Muller M, Frausto RF, et al. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 2009; 183:2079-2088.
    • (2009) J Immunol , vol.183 , pp. 2079-2088
    • Quintana, A.1    Muller, M.2    Frausto, R.F.3
  • 38
    • 70349883885 scopus 로고    scopus 로고
    • Spinal cord lesions in patients with neuromyelitis optica: A retrospective long-term MRI follow-up study
    • Krampla W, Aboul-Enein F, Jecel J, et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009; 19:2535-2543.
    • (2009) Eur Radiol , vol.19 , pp. 2535-2543
    • Krampla, W.1    Aboul-Enein, F.2    Jecel, J.3
  • 39
    • 33644901308 scopus 로고    scopus 로고
    • Brain abnormalities in neuromyelitis optica
    • Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63:390-396.
    • (2006) Arch Neurol , vol.63 , pp. 390-396
    • Pittock, S.J.1    Lennon, V.A.2    Krecke, K.3
  • 40
    • 70350056914 scopus 로고    scopus 로고
    • "cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica
    • Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66:425-428.
    • (2009) Ann Neurol , vol.66 , pp. 425-428
    • Ito, S.1    Mori, M.2    Makino, T.3
  • 41
    • 84860780841 scopus 로고    scopus 로고
    • Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders
    • [Epub ahead of print]
    • Banker P, Sonni S, Kister I, et al. Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler 2011. [Epub ahead of print]
    • (2011) Mult Scler
    • Banker, P.1    Sonni, S.2    Kister, I.3
  • 42
    • 77955456303 scopus 로고    scopus 로고
    • Interferon beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers
    • Palace J, Leite MI, Nairne A, Vincent A. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 2010; 67:1016-1017.
    • (2010) Arch Neurol , vol.67 , pp. 1016-1017
    • Palace, J.1    Leite, M.I.2    Nairne, A.3    Vincent, A.4
  • 43
    • 78049510106 scopus 로고    scopus 로고
    • IFNb-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
    • Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNb-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010; 75:1423-1427.
    • (2010) Neurology , vol.75 , pp. 1423-1427
    • Shimizu, J.1    Hatanaka, Y.2    Hasegawa, M.3
  • 44
    • 84862908479 scopus 로고    scopus 로고
    • Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
    • Min JH, Kim BJ, Lee KH. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler 2012; 18:113-115.
    • (2012) Mult Scler , vol.18 , pp. 113-115
    • Min, J.H.1    Kim, B.J.2    Lee, K.H.3
  • 45
    • 80053583158 scopus 로고    scopus 로고
    • Impact of rituximab on relapse rate and disability in neuromyelitis optica
    • Bedi GS, Brown AD, Delgado SR, et al. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult Scler 2011; 17:1225-1230.
    • (2011) Mult Scler , vol.17 , pp. 1225-1230
    • Bedi, G.S.1    Brown, A.D.2    Delgado, S.R.3
  • 46
    • 80055095675 scopus 로고    scopus 로고
    • Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
    • Costanzi C, Matiello M, Lucchinetti CF, et al. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology 2011; 77:659-666.
    • (2011) Neurology , vol.77 , pp. 659-666
    • Costanzi, C.1    Matiello, M.2    Lucchinetti, C.F.3
  • 47
    • 79958112517 scopus 로고    scopus 로고
    • Transient increases in antiaquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels
    • Nakashima I, Takahashi T, Cree BA, et al. Transient increases in antiaquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. J Clin Neurosci 2011; 18:997-998.
    • (2011) J Clin Neurosci , vol.18 , pp. 997-998
    • Nakashima, I.1    Takahashi, T.2    Cree, B.A.3
  • 48
    • 34249821083 scopus 로고    scopus 로고
    • Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
    • Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol 2007; 14:e12-e13.
    • (2007) Eur J Neurol , vol.14
    • Gartzen, K.1    Limmroth, V.2    Putzki, N.3
  • 49
    • 35448977649 scopus 로고    scopus 로고
    • Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica
    • Okada K, Tsuji S, Tanaka K. Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 2007; 46:1671-1672.
    • (2007) Intern Med , vol.46 , pp. 1671-1672
    • Okada, K.1    Tsuji, S.2    Tanaka, K.3
  • 50
    • 33846528659 scopus 로고    scopus 로고
    • Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica
    • Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007; 13:128-132.
    • (2007) Mult Scler , vol.13 , pp. 128-132
    • Watanabe, S.1    Nakashima, I.2    Misu, T.3
  • 51
    • 33745858352 scopus 로고    scopus 로고
    • Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)
    • Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 2006; 63:957-963.
    • (2006) Arch Neurol , vol.63 , pp. 957-963
    • Weinstock-Guttman, B.1    Ramanathan, M.2    Lincoff, N.3
  • 52
    • 84855881248 scopus 로고    scopus 로고
    • Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
    • [Epub ahead of print]
    • Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2011. [Epub ahead of print]
    • (2011) Ann Neurol
    • Tradtrantip, L.1    Zhang, H.2    Saadoun, S.3
  • 53
    • 84860898728 scopus 로고    scopus 로고
    • Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
    • [Epub ahead of print]
    • Tradtrantip L, Zhang H, Anderson MO, et al. Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012. [Epub ahead of print]
    • (2012) FASEB J
    • Tradtrantip, L.1    Zhang, H.2    Anderson, M.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.